Reference record for OID 2.16.840.1.113883.11.21026

Parent
2.16.840.1.113883.11 (valueSets)
Node code
21026
Node names
  • AdverseEventCRSerCrit
  • adverse-event-clinical-research-seriousness-criteria
Numeric OID
2.16.840.1.113883.11.21026
URN notation
urn:oid:2.16.840.1.113883.11.21026
ASN.1 notation

{2 16 840 1 113883 11 21026}

  • {joint-iso-itu-t(2) country(16) us(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-itu-t(2) country(16) us-joint(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-ccitt(2) country(16) us(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-ccitt(2) country(16) us-joint(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
OID-IRI notation
  • /2/16/840/1/113883/11/21026
  • /Country/840/1/113883/11/21026
  • /Joint-ISO-ITU-T/16/840/1/113883/11/21026
Named path variants
  • /joint-iso-itu-t/country/us/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us-joint/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us-joint/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us-joint/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us-joint/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us-joint/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us-joint/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us-joint/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us-joint/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria

Descriptions

AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria — HL7 Terminology

Action criteria usually associated with serious events that pose a threat to a patient's life or functioning. Adverse Events criteria to expand on the seriousness of the adverse event. Typically used in reporting for Clinical Research, post-market surveillance (e.g. Form FDA 3500A MedWatch). The adverse event seriousness criteria value set is based on the ICH E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting guidance (https://database.ich.org/sites/default/files/E2D_Guideline.pdf). For information on ICH see https://admin.ich.org/sites/default/files/inline-files/OID_Information_Paper_1.pdf from the INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE (ICH) document ICH E2B(R3), the Electronic Transmission of Individual Case Safety Reports (ICSRs) Implementation Guide Data Elements and Message Specification, and ICH M8, the Electronic Common Technical Document

Source records

AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria

Status in source: active.

Names: AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria

Technical details
{
  "url": "http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-seriousness-criteria",
  "date": "2023-07-28T19:27:19+00:00",
  "title": "Adverse Event Clinical Research Seriousness Criteria",
  "status": "active",
  "contact": [
    {
      "telecom": [
        {
          "value": "http://hl7.org",
          "system": "url"
        },
        {
          "value": "hq@HL7.org",
          "system": "email"
        }
      ]
    }
  ],
  "version": "1.0.0",
  "copyright": "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
  "publisher": "Health Level Seven International",
  "experimental": false,
  "resource_type": "ValueSet",
  "oid_identifier": {
    "value": "urn:oid:2.16.840.1.113883.11.21026",
    "system": "urn:ietf:rfc:3986"
  }
}

First Registration Authority (inferred from ancestor 2.16.840.1.113883)

W. Ted Klein

Current Registration Authority (inferred from ancestor 2.16.840.1)

Karen Hughes

Siblings (1453)

OIDNameDirect childrenDescendantsDescription
2.16.840.1.113883.11.13955 actEncounterCode, ActEncounterCode00
2.16.840.1.113883.11.13957 actSpecObsCode, ActSpecObsCode00
2.16.840.1.113883.11.13988 entityHandling, EntityHandling00
2.16.840.1.113883.11.14002 actClassContract, ActClassContract00
2.16.840.1.113883.11.14003 actClassFinancialContract, ActClassFinancialContract00
2.16.840.1.113883.11.14006 roleClassAgent, RoleClassAgent00
2.16.840.1.113883.11.14008 x-RoleClassCoverage00 x_RoleClassCoverage
2.16.840.1.113883.11.14013 x-RoleClassCoverageInvoice00 x_RoleClassCoverageInvoice
2.16.840.1.113883.11.14040 actSpecimenTreatmentCode, ActSpecimenTreatmentCode00
2.16.840.1.113883.11.14049 containerCap, ContainerCap00
2.16.840.1.113883.11.14054 containerSeparator, ContainerSeparator00
2.16.840.1.113883.11.14058 actContainerRegistrationCode, ActContainerRegistrationCode00
2.16.840.1.113883.11.14066 deviceAlertLevel, DeviceAlertLevel00
2.16.840.1.113883.11.14079 observationMethod, ObservationMethod00
2.16.840.1.113883.11.14352 actSpecObsDilutionCode, ActSpecObsDilutionCode00
2.16.840.1.113883.11.14369 actSpecObsVolumeCode, ActSpecObsVolumeCode00
2.16.840.1.113883.11.14382 actSpecObsInterferenceCode, ActSpecObsInterferenceCode00
2.16.840.1.113883.11.14411 orderableDrugForm, OrderableDrugForm00
2.16.840.1.113883.11.14412 dispensableDrugForm, DispensableDrugForm00
2.16.840.1.113883.11.14413 liquid, Liquid00
2.16.840.1.113883.11.14414 liquidCleanser, LiquidCleanser00
2.16.840.1.113883.11.14417 oilDrugForm, OilDrugForm00
2.16.840.1.113883.11.14419 solutionDrugForm, SolutionDrugForm00
2.16.840.1.113883.11.14420 dropsDrugForm, DropsDrugForm00
2.16.840.1.113883.11.14427 irrigationSolution, IrrigationSolution00
2.16.840.1.113883.11.14431 oralSolution, OralSolution00
2.16.840.1.113883.11.14437 topicalSolution, TopicalSolution00
2.16.840.1.113883.11.14441 liquidSolidSuspension, LiquidSolidSuspension00
2.16.840.1.113883.11.14442 gelDrugForm, GelDrugForm00
2.16.840.1.113883.11.14449 vaginalGel, VaginalGel00
2.16.840.1.113883.11.14451 pasteDrugForm, PasteDrugForm00
2.16.840.1.113883.11.14454 suspensionDrugForm, SuspensionDrugForm00
2.16.840.1.113883.11.14457 oralSuspension, OralSuspension00
2.16.840.1.113883.11.14458 extendedReleaseSuspension, ExtendedReleaseSuspension00
2.16.840.1.113883.11.14463 liquidLiquidEmulsion, LiquidLiquidEmulsion00
2.16.840.1.113883.11.14464 lotionDrugForm, LotionDrugForm00
2.16.840.1.113883.11.14466 creamDrugForm, CreamDrugForm00
2.16.840.1.113883.11.14473 vaginalCream, VaginalCream00
2.16.840.1.113883.11.14475 ointmentDrugForm, OintmentDrugForm00
2.16.840.1.113883.11.14482 vaginalOintment, VaginalOintment00
2.16.840.1.113883.11.14484 solidDrugForm, SolidDrugForm00
2.16.840.1.113883.11.14485 barDrugForm, BarDrugForm00
2.16.840.1.113883.11.14486 barSoapDrugForm, BarSoapDrugForm00
2.16.840.1.113883.11.14497 padDrugForm, PadDrugForm00
2.16.840.1.113883.11.14499 patchDrugForm, PatchDrugForm00
2.16.840.1.113883.11.14500 transdermalPatch, TransdermalPatch00
2.16.840.1.113883.11.14506 pillDrugForm, PillDrugForm00
2.16.840.1.113883.11.14507 capsuleDrugForm, CapsuleDrugForm00
2.16.840.1.113883.11.14508 oralCapsule, OralCapsule00
2.16.840.1.113883.11.14509 entericCoatedCapsule, EntericCoatedCapsule00